Alkem Laboratories is looking to tap domestic as well as international markets, for growth going forward. The company is looking to consolidate its market leading position in its established therapy areas of anti-infectives, gastro-intestinal, pain management and vitamins, minerals & nutrients.
In the domestic market, the company plans to consolidate presence in the segments it is in and is aiming to build base in the emerging therapy areas and over the counter (OTC) segment. The Mumbai-based firm is also looking at building base in the emerging therapy areas of cardiac, anti-diabetes, CNS and derma (skin) by leveraging on its core strengths.
Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.
